SNCA and Parkinson disease: The interplay between mitochondria and α-synuclein during the progression of PD still constitutes an issue to be solved, as the exact contribution of mitochondrial deficits and α-synuclein aggregation to dopaminergic neurons degeneration has yet to be clearly elucidated (69, 70).